Effectiveness and safety of omalizumab in severe, persistent IgE-mediated asthma in pediatric and adult patients: a real-world observational study in Egyptian population. [electronic resource]
Producer: 20201007Description: 160-166 p. digitalISSN:- 1532-4303
- Absenteeism
- Adolescent
- Adrenal Cortex Hormones -- therapeutic use
- Adrenergic beta-2 Receptor Agonists -- therapeutic use
- Adult
- Aged
- Aged, 80 and over
- Anti-Asthmatic Agents -- administration & dosage
- Asthma -- drug therapy
- Child
- Drug Therapy, Combination
- Egypt
- Female
- Forced Expiratory Volume -- drug effects
- Humans
- Hypergammaglobulinemia -- epidemiology
- Immunoglobulin E -- blood
- Male
- Middle Aged
- Omalizumab -- administration & dosage
- Prospective Studies
- Quality of Life
- Respiratory Function Tests
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.